Literature DB >> 3815311

Cancer incidence in hypertensives.

C Buck, A Donner.   

Abstract

Cancer incidence was measured over a 5-year period (1978 to 1982) in 4067 hypertensive patients, and 10,366 normotensive patients from general practices in southwestern Ontario. For cancer of all sites an elevated incidence was found among hypertensive patients. The elevation was most pronounced among newly diagnosed hypertensive patients, with hypertension of moderate or greater severity, and for sites that have been described in clinical reports as being capable of producing a rise in blood pressure. It is tentatively concluded that the causal direction is from cancer to hypertension, rather than the reverse. If this conclusion is correct, the associations that have been reported between cancer mortality and hypertension may be due to an effect of blood pressure upon survival from cancer.

Entities:  

Mesh:

Year:  1987        PMID: 3815311     DOI: 10.1002/1097-0142(19870401)59:7<1386::aid-cncr2820590726>3.0.co;2-b

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment response.

Authors:  S Sud; C O'Callaghan; C Jonker; C Karapetis; T Price; N Tebbutt; J Shapiro; G Van Hazel; N Pavlakis; P Gibbs; M Jeffrey; L Siu; S Gill; R Wong; D Jonker; D Tu; R Goodwin
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

2.  Renal cell carcinoma and thiazide use: a historical, case-control study (California, USA).

Authors:  R A Hiatt; K Tolan; C P Quesenberry
Journal:  Cancer Causes Control       Date:  1994-07       Impact factor: 2.506

3.  Hypertensive nephropathy and cancer: Is it the hypertension, the nephropathy, or both?

Authors:  Sabine Karam
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-24       Impact factor: 3.738

4.  Hypertensive nephropathy is associated with an increased risk of myeloma, skin, and renal cancer.

Authors:  James Goya Heaf; Alastair Hansen; Gunnar Hellmund Laier
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-05-24       Impact factor: 3.738

Review 5.  Antihypertensive therapy and cancer risk.

Authors:  D C Felmeden; G Y Lip
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

Review 6.  Critical review of cancer risk associated with angiotensin receptor blocker therapy.

Authors:  Grégoire Wuerzner; Michel Burnier; Bernard Waeber
Journal:  Vasc Health Risk Manag       Date:  2011-12-12

7.  Blood pressure and site-specific cancer mortality: evidence from the original Whitehall study.

Authors:  G D Batty; M J Shipley; M G Marmot; G Davey Smith
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.